The National Dementia Action Alliance’s first call to action was launched in 2011 on the use of antipsychotic drugs for people with dementia. The aim of the call to action was to see all people living with dementia, who are receiving antipsychotic drugs, receive a clinical review from their doctor to ensure that their care complied with current best practice and guidelines and that alternatives to medication were considered by 31 March 2012.
The inappropriate prescribing of antipsychotic medication can have significant consequences for a person receiving these. Antipsychotics can increase people’s symptoms of dementia and cause dizziness and unsteadiness, leading to falls and injuries and robbing people of their quality of life. Some side-effects include mobility problems, sedation and sometimes death, particularly when used for longer than 12 weeks.
To reduce the use of these drugs, people with dementia, their carers, GPs, leaders in care homes and pharmacists, were asked to commit to outlining how they can play their part in ensuring reviews take place. A guide on best practice on the use of antipsychotics was also produced for people with dementia and carers and health and social care professionals.
To access this guide please, download it below.
An economic evaluation of alternatives to antipsychotic drugs for individuals living with dementia was also been published and is available to download below.Download